 |
|
| Blog results | Results 1 - 10 of about 1,137 for apo simvastatin. (0.21 seconds) |
| Sorted by relevance Sort by date |
| 6 Aug 2009 by admin Simvastatin (Zocor, Apo-Simvastatin, Revastat, Simvacor, Lisac, Cardin). Sotalol (Betapace, Alti-Sotalol). Telmisartan and Hydrochlorothiazide (Micardis-HCT, Micardis Plus). Thiethylperazine (Torecan) ... DearPharmacist - http://72.167.236.127/dearpharmacist/ |
| 31 Aug 2009 by Prne Lipid and lipoprotein fractions assessed: - Total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), non-HDL-C, TC:HDL-C ratio, non HDL-C:HDL-C ratio, triglycerides (TG), apolipoprotein B (Apo-B) and apolipoprotein A1 ... PR Hub - http://blog.taragana.com/pr/ |
| 16 Nov 2009 by (청년 의사) 그러나 최근 여러 대규모 임상연구의 결과 분석을 통해 TC보다는 LDL:HDL ratio 또는 Apo B:Apo A-1 ratio 가 더욱 밀접한 관련성을 가지고 있으므로 이러한 지표를 개선시키는 방향으로 지질개선 치료가 시행되어야 한다는 의견이 대두되고 있다. .... 실제로 simvastatin과 ezetimibe 병용투여에서 LDL:HDL Ratio가 약간 증가한 소견을 보였다. Ezetimibe가 TG를 감소시키기 때문에 HDL에 영향을 주지만, 결론적으로 두 투약군의 LDL:HDL Ratio 차이는 통계적으로 유의한 수준이 아니었다. ... 청년의사 - http://doc3.koreahealthlog.com/ |
| 3 Mar 2008 by Heather Meier brown gives muted welcome to new russian president. vice president of global clinical development for abbott. patientswith diabetes should carefully monitor their blood sugar and report changes totheir doctor. ... S china Hu Jintao to visit Japan from - http://blogs.puyallupherald.com/prothathigh/ |
| 25 Oct 2009 LIVALO Superior to Simvastatin in Reducing LDL-C When Comparing Starting Doses New Phase III data published today in Current Medical Research and Opinion highli. ... LIVALO® was approved by the U.S. Food and Drug Administration in August 2009 as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C in adult patients with primary ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 10 Jun 2009 by Tremblay, A. J, Lamarche, B., Hogue, J.-C.,... ... placebo-controlled, double-blind, cross-over study to evaluate the effect of ezetimibe 10 mg and simvastatin 40 mg, coadministered and alone, on the in vivo kinetics of apolipoprotein (apo) B-48 and B-100 in humans. ... The Journal of Lipid Research current issue - http://www.jlr.org/ |
| 1 Dec 2008 by Michael H. Davidson, Nicola Abate, Christie... This analysis examined the percent of patients in prespecified dose comparisons and overall achievement of LDL-C <70 mg/dL and/or Apo-B <90 mg/dL, total cholesterol (TC)/HDL-C <4.0, or Apo-B/Apo-A-I <0.7 among all treated patients, ... Journal of Clinical Lipidology - http://www.lipidjournal.com/?rss=yes |
| 26 Feb 2009 When patients receiving VYTORIN were compared to those receiving all doses of simvastatin, VYTORIN significantly lowered total-C, LDL-C, Apo B, TG, and non-HDL-C. The effects of VYTORIN on HDL-C were similar to the effects seen with ... RxList - News and Features - http://www.rxlist.com/script/main/hp.asp - References [ More results from RxList - News and Features ] |
| 26 May 2006 Compare the effect of 20 mg simvastatin vs 10 mg of simvastatin with and without psyllium on total cholesterol, LDL-C, and Apo B and apolipoprotein A-1 (Apo A-1) levels in patients with hypercholesterolemia. ... Medscape Cardiology Headlines - http://www.medscape.com/cardiology |
| 15 Apr 2008 by christi ... vytorin medicine simvastatin dr reddys simvastatin simvastatin tab grapefruit simvastatin effect side simvastatin 10mg simvastatin dr reddy simvastatin 20 dose mg simvastatin apo simvastatin dosage simvastatin alcohol simvastatin. scams - http://www.scam.com/ [ More results from scams ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
